ATE430600T1 - 2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid - Google Patents

2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid

Info

Publication number: ATE430600T1
Authority: AT; Austria
Prior art keywords: methyl; phenyl; trifluormethyl; isobutyramide; dio
Prior art date: 2001-07-31

Application number

AT02791471T

Other languages

English (en)

Inventor

Theresa Ballard

Torsten Hoffmann

Sonia Poli

Patrick Schnider

Andrew Sleight

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-31

Filing date

2002-07-26

Publication date

2009-05-15

2002-07-26 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2009-05-15 Application granted granted Critical

2009-05-15 Publication of ATE430600T1 publication Critical patent/ATE430600T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Otolaryngology (AREA)
Addiction (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

AT02791471T 2001-07-31 2002-07-26 2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid ATE430600T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01118412		2001-07-31
PCT/EP2002/008311 WO2003011860A2 (en)	2001-07-31	2002-07-26	2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE

Publications (1)

Publication Number	Publication Date
ATE430600T1 true ATE430600T1 (de)	2009-05-15

Family

ID=8178193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02791471T ATE430600T1 (de)	2001-07-31	2002-07-26	2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid

Country Status (30)

Country	Link
US (1)	US6849624B2 (de)
EP (1)	EP1414525B1 (de)
JP (1)	JP4700908B2 (de)
KR (1)	KR100577101B1 (de)
CN (1)	CN1289497C (de)
AR (1)	AR034921A1 (de)
AT (1)	ATE430600T1 (de)
BR (1)	BR0211523A (de)
CA (1)	CA2452502C (de)
DE (1)	DE60232246D1 (de)
EA (1)	EA006238B1 (de)
EC (1)	ECSP044963A (de)
ES (1)	ES2324209T3 (de)
GT (1)	GT200200159A (de)
HK (1)	HK1069136A1 (de)
HR (1)	HRP20040039A2 (de)
HU (1)	HUP0400398A3 (de)
MA (1)	MA27055A1 (de)
MX (1)	MXPA04000917A (de)
MY (1)	MY128464A (de)
NO (1)	NO20040404L (de)
NZ (1)	NZ530579A (de)
PA (1)	PA8551601A1 (de)
PE (1)	PE20030276A1 (de)
PL (1)	PL366986A1 (de)
UA (1)	UA77685C2 (de)
UY (1)	UY27403A1 (de)
WO (1)	WO2003011860A2 (de)
YU (1)	YU2704A (de)
ZA (1)	ZA200400652B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100599134B1 (ko) *	2001-04-23	2006-07-12	에프. 호프만-라 로슈 아게	양성 전립선 비대증에 대한 ｎｋ-1 수용체 길항물질의 용도
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
AU2003293987B2 (en)	2002-12-20	2010-09-09	Niconovum Ab	A physically and chemically stable nicotine-containing particulate material
WO2004067007A1 (en) *	2003-01-31	2004-08-12	F. Hoffmann-La Roche Ag	NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4(4-FLUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
WO2006002860A1 (en)	2004-07-06	2006-01-12	F. Hoffmann-La Roche Ag	Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 receptor antagonists
AU2006218179B2 (en) *	2005-02-22	2010-12-23	F. Hoffmann-La Roche Ag	NK1 antagonists
BRPI0606187A2 (pt)	2005-02-25	2009-06-09	Hoffmann La Roche	comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
JP5694645B2 (ja)	2006-03-16	2015-04-01	ニコノヴァムエービーＮｉｃｏｎｏｖｕｍＡｂ	改善された嗅ぎたばこ組成物
GB0808747D0 (en)	2008-05-14	2008-06-18	Glaxo Wellcome Mfg Pte Ltd	Novel compounds
US10383894B2 (en) *	2010-03-17	2019-08-20	Lutran Industries, Inc.	Human medicinal treatment using salt of peroxymonosulfuric acid
ES2671418T3 (es)	2013-11-08	2018-06-06	Kissei Pharmaceutical Co., Ltd.	Derivado de carboximetilpiperidina
TWI649307B (zh)	2014-05-07	2019-02-01	日商橘生藥品工業股份有限公司	Cyclohexylpyridine derivative
EP3730140A1 (de) *	2015-03-04	2020-10-28	Vanda Pharmaceuticals Inc.	Verfahren zur behandlung mit tradipitant
US20210228555A1 (en) *	2018-06-08	2021-07-29	Vanda Pharmaceuticals Inc.	Method of treatment with tradipitant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6435115A (en) *	1987-07-31	1989-02-06	Nippon Seiko Kk	Bearing device
IL111960A (en)	1993-12-17	1999-12-22	Merck & Co Inc	Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
US5612337A (en)	1993-12-29	1997-03-18	Merck Sharp & Dohme Limited	Substituted morpholine derivatives and their use as therapeutic agents
IL112778A0 (en)	1994-03-04	1995-05-26	Merck & Co Inc	Substituted heterocycles, their preparation and pharmaceutical compositions containing them
US5972938A (en)	1997-12-01	1999-10-26	Merck & Co., Inc.	Method for treating or preventing psychoimmunological disorders
SI1035115T1 (en)	1999-02-24	2005-02-28	F. Hoffmann-La Roche Ag	4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
KR100599134B1 (ko)	2001-04-23	2006-07-12	에프. 호프만-라 로슈 아게	양성 전립선 비대증에 대한 ｎｋ-1 수용체 길항물질의 용도

2002
- 2002-07-17 US US10/196,795 patent/US6849624B2/en not_active Expired - Fee Related
- 2002-07-25 PE PE2002000667A patent/PE20030276A1/es not_active Application Discontinuation
- 2002-07-26 NZ NZ530579A patent/NZ530579A/en unknown
- 2002-07-26 YU YU2704A patent/YU2704A/sh unknown
- 2002-07-26 AT AT02791471T patent/ATE430600T1/de active
- 2002-07-26 WO PCT/EP2002/008311 patent/WO2003011860A2/en active IP Right Grant
- 2002-07-26 PA PA20028551601A patent/PA8551601A1/es unknown
- 2002-07-26 KR KR1020047001322A patent/KR100577101B1/ko not_active IP Right Cessation
- 2002-07-26 DE DE60232246T patent/DE60232246D1/de not_active Expired - Lifetime
- 2002-07-26 EA EA200400109A patent/EA006238B1/ru not_active IP Right Cessation
- 2002-07-26 CN CNB028151100A patent/CN1289497C/zh not_active Expired - Fee Related
- 2002-07-26 UA UA2004021462A patent/UA77685C2/uk unknown
- 2002-07-26 MX MXPA04000917A patent/MXPA04000917A/es active IP Right Grant
- 2002-07-26 EP EP02791471A patent/EP1414525B1/de not_active Expired - Lifetime
- 2002-07-26 PL PL02366986A patent/PL366986A1/xx not_active Application Discontinuation
- 2002-07-26 ES ES02791471T patent/ES2324209T3/es not_active Expired - Lifetime
- 2002-07-26 HU HU0400398A patent/HUP0400398A3/hu unknown
- 2002-07-26 BR BR0211523-9A patent/BR0211523A/pt not_active Application Discontinuation
- 2002-07-26 JP JP2003517052A patent/JP4700908B2/ja not_active Expired - Fee Related
- 2002-07-26 CA CA2452502A patent/CA2452502C/en not_active Expired - Fee Related
- 2002-07-29 AR ARP020102847A patent/AR034921A1/es not_active Application Discontinuation
- 2002-07-29 MY MYPI20022848A patent/MY128464A/en unknown
- 2002-07-30 UY UY27403A patent/UY27403A1/es not_active Application Discontinuation
- 2002-07-31 GT GT200200159A patent/GT200200159A/es unknown
2004
- 2004-01-15 HR HR20040039A patent/HRP20040039A2/hr not_active Application Discontinuation
- 2004-01-27 ZA ZA200400652A patent/ZA200400652B/xx unknown
- 2004-01-29 EC EC2004004963A patent/ECSP044963A/es unknown
- 2004-01-29 NO NO20040404A patent/NO20040404L/no unknown
- 2004-01-30 MA MA27507A patent/MA27055A1/fr unknown
2005
- 2005-02-28 HK HK05101662A patent/HK1069136A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HRP20040039A2 (en)	2004-06-30
US6849624B2 (en)	2005-02-01
MXPA04000917A (es)	2004-04-02
MY128464A (en)	2007-02-28
HK1069136A1 (en)	2005-05-13
WO2003011860A3 (en)	2003-09-04
UY27403A1 (es)	2003-04-30
JP2005500354A (ja)	2005-01-06
DE60232246D1 (de)	2009-06-18
EA200400109A1 (ru)	2004-08-26
US20030064983A1 (en)	2003-04-03
PA8551601A1 (es)	2003-06-30
CN1537025A (zh)	2004-10-13
ZA200400652B (en)	2005-04-28
ECSP044963A (es)	2004-03-23
BR0211523A (pt)	2004-09-14
AR034921A1 (es)	2004-03-24
CA2452502C (en)	2011-02-15
JP4700908B2 (ja)	2011-06-15
ES2324209T3 (es)	2009-08-03
YU2704A (sh)	2006-08-17
CA2452502A1 (en)	2003-02-13
EP1414525B1 (de)	2009-05-06
WO2003011860A2 (en)	2003-02-13
PL366986A1 (en)	2005-02-07
KR100577101B1 (ko)	2006-05-10
UA77685C2 (en)	2007-01-15
NO20040404L (no)	2004-01-29
MA27055A1 (fr)	2004-12-20
EA006238B1 (ru)	2005-10-27
PE20030276A1 (es)	2003-03-29
AU2002355652B2 (en)	2007-07-05
GT200200159A (es)	2003-05-16
HUP0400398A3 (en)	2010-06-28
KR20040029386A (ko)	2004-04-06
NZ530579A (en)	2006-02-24
HUP0400398A2 (hu)	2004-09-28
CN1289497C (zh)	2006-12-13
EP1414525A2 (de)	2004-05-06

Publication	Publication Date	Title
BR0216099B1 (pt)	2013-12-03	"conjunto de desgaste".
FR14C0066I2 (fr)	2015-05-22	2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
DE60314124D1 (de)	2007-07-12	2-(2,6-dichlorphenyl)-diarylimidazole
DK2308855T3 (da)	2013-01-28	2,4-Diaminopyrimidinderivater
ITTO20011189A0 (it)	2001-12-18	Macchina pallettizzatrice.
NO20042474L (no)	2004-08-11	Reguleringsventil-stromningsjusteringsanordning.
ATE430600T1 (de)	2009-05-15	2-(3,5-bis-trifluormethyl-phenyl)-n- 6-(1,1-dio o-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl- oder 4-fluor-2-methyl-substituiertes)phenyl-pyridin- - yl -n-methyl-isobutyramid
IT1320120B1 (it)	2003-11-18	2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il) -isobutirrammide.
DE60129750D1 (de)	2007-09-13	Antiblend-, antibeschlagselement
DE60138903D1 (de)	2009-07-16	N-(1,2,4-triazoloazinyl)thiophensulfonamid-verbindungen als herbizide
NO20030868L (no)	2003-04-04	N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
NO20042980L (no)	2004-07-14	3,4-dihydro-1H-isokinolin-2-yl-derivater
DE60315471D1 (de)	2007-09-20	2,5-disubstituierte 3-mercaptopentansaure
ATE263165T1 (de)	2004-04-15	3-(4,5-dihydroisoxazol-5-yl)benzoylpyrazole
ATE365725T1 (de)	2007-07-15	Biologisch aktive 4h-benzo 1,4öoxazin-3-one
DZ3441A1 (fr)	2002-08-29	Nouvelles phenylpiperazines.
DE60232170D1 (de)	2009-06-10	Thieno-(1,3)-oxazin-4-one mit lipase inhibierender wirkung
AR027974A1 (es)	2003-04-23	1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
ATE470655T1 (de)	2010-06-15	Substituierte 1,5-diaminopentan-3-ol-verbindungen
IS7131A (is)	2004-01-29	Nýjar 2,4-díamínóþíasól afleiður
ES1048400Y (es)	2001-12-16	Bota-patin mejorada.
DOP2001000274A (es)	2002-05-30	Inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas
ES1049329Y (es)	2002-04-16	Ladrillo perfeccionado.
IS7299A (is)	2004-06-03	3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ES1049952Y (es)	2002-06-01	Maquina de juego-expendedora mejorada.

Legal Events

Date	Code	Title	Description
2009-11-15	UEP	Publication of translation of european patent specification	Ref document number: 1414525 Country of ref document: EP

Date

Code

Title

Description

2009-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1414525

Country of ref document: EP